FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, to allergology and immunology, and can be used for treating patients with allergic rhinitis associated with chronic rhinosinusitis of bacterial etiology. For this purpose, a topical immune corrector "KIP nasal" is used as an immunomodulatory product, constituting a lyophilised protein solution containing IgG, IgA, IgM-class immunoglobulins isolated from human blood plasma, administered intranasally 5 drops into each nasal passage 3 times per day for 5 days.
EFFECT: method ensures effective treatment of allergic rhinitis associated with chronic rhinosinusitis of bacterial etiology, reduces the frequency of exacerbations and hospitalisations, reduces the volume of basic and antibacterial therapy due to the normalisation of a number of indicators of the mucosal immunity.
1 cl, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS WITH CONCOMITANT TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2763672C1 |
METHOD OF EVALUATING THE EFFICIENCY OF MEDICAMENTAL THERAPY OF ACUTE EXACERBATIONS OF CHRONIC PURULENT SINUSITIS | 2015 |
|
RU2600645C2 |
METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
METHOD FOR SELECTING TARGETED THERAPY IN CHRONIC T2-INFLAMMATORY DISEASES OF NASAL CAVITY AND PARANASAL SINUSES | 2023 |
|
RU2824263C1 |
DIAGNOSTIC TECHNIQUE FOR SECONDARY IMMUNODEFICIENT DISEASE IN PULMONARY TUBERCULOSIS | 2012 |
|
RU2504784C1 |
METHOD OF REHABILITATION OF PATIENTS WITH BRONCHIAL ASTHMA WITH ACCOMPANYING ALLERGIC RHINITIS | 2010 |
|
RU2454088C2 |
METHOD FOR ASSESSMENT OF EFFICIENCY OF ALLERGEN-SPECIFIC IMMUNOTHERAPY IN ALLERGIC RHINITIS | 2019 |
|
RU2700788C1 |
METHOD OF TREATING CHRONIC GASTRODUODENITIS ASSOCIATED WITH INFECTION CAUSED BY BACTERIA Helicobacter pylori IN ALLERGIC DISEASES | 2011 |
|
RU2472498C1 |
METHOD OF TREATING PATIENTS WITH PERENNIAL ALLERGIC RHINITIS WITH UNSTABLE REMISSIONS WITH UNDERLYING PERSISTENT RESPIRATORY CHLAMYDIAL INFECTION | 2024 |
|
RU2825050C1 |
METHOD FOR TREATMENT OF HEAVY FORMS OF PSORIASIS | 2016 |
|
RU2620552C1 |
Authors
Dates
2021-11-30—Published
2020-11-30—Filed